STAT+: OHSU board votes to negotiate with NIH and possibly transform its primate center into an animal sanctuary
Stat News • 2/9/2026 – 2/10/2026
Summary
The OHSU board has voted to negotiate with the NIH regarding the potential transformation of its primate center into an animal sanctuary. This decision aligns with the NIH's initiative to transition at least one of the seven national primate research centers into an animal sanctuary.
Advertisement
Lindy Score Breakdown (V4.2)
53d
Age
1
Sources
from cluster
1252
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1252/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1252/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 52 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • Today
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Stat News • Today
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 1 day ago
STAT+: How health care could gum up Trump’s reconciliation push
Stat News • Today
STAT+: Can a psychedelic ‘coach’ make ketamine therapy even more effective?
Stat News • 2 days ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 1 day ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • Today
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Stat News • Today
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Stat News • 1 day ago
STAT+: Large AI scribe study finds modest time savings, inconsistent use
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 3 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago